Caffeinated Energy Drinks Linked to Elevated Cardiac Arrest Reports

Emerging evidence indicates that energy drinks and stimulant supplements are linked to heightened heart‑health concerns, as researchers identified a pronounced pattern in reports of serious cardiovascular events. Products containing caffeine or other stimulants were reported far more often in cases of cardiac arrest, heart attacks, and related cardiac issues compared with products lacking these ingredients.

The findings are especially worrisome for younger adults; individuals aged 18 to 34 represented a large proportion of reported cardiac events tied to caffeinated products, according to independent preliminary research presented at the American Heart Association Scientific Sessions 2026.

Researchers stressed that the data do not prove causation between energy drinks or stimulant supplements and the reported emergencies. Nevertheless, the markedly higher incidence of specific cardiovascular events in FDA safety reports indicates that these readily available products merit further scrutiny.

Growing Concerns About Energy Drinks and Heart Health

The energy‑drink market has expanded rapidly, with sales more than doubling in the last decade to surpass $20 billion in 2024. Yet, scientific understanding of the cardiovascular impact of energy drinks and stimulant‑containing supplements remains limited.

Existing evidence indicates that excessive caffeine intake can damage the cardiovascular system. Medical professionals have documented arrhythmias, sudden cardiac death, and other heart‑related events after consuming these products, including cases among young adults without prior heart‑disease risk factors.

A 2026 American Heart Association Scientific Statement on caffeine and cardiovascular disease notes that most adults may safely consume up to 400 mg of caffeine per day—approximately the amount in five 8‑ounce servings of regular black coffee—without significant safety concerns.

However, caffeine concentrations vary widely across products. Some energy drinks contain up to three times the caffeine per fluid ounce found in brewed coffee, and certain pre‑workout supplements may exceed coffee’s caffeine concentration by more than twelvefold.

Regulatory concerns also arise because the U.S. Food and Drug Administration classifies energy drinks and stimulant supplements as foods or dietary supplements, not medications. Consequently, they are exempt from the rigorous safety testing required for pharmaceuticals before market approval.

“These products are marketed as everyday pick‑me‑ups and sold next to soda and bottled water, so most people assume they carry no real risk,” said study author Sai Samayamanthula, a fourth‑year medical student at the University of Virginia School of Medicine in Charlottesville, Virginia. “For many healthy people, occasional consumption probably poses minimal risk. However, individuals who regularly use energy drinks or stimulant‑containing supplements can quickly exceed the recommended daily caffeine limit, making it important for people to be aware of the potential cardiovascular risk associated with these products.”

FDA Reports Reveal Striking Differences in Cardiac Events

To assess potential cardiovascular safety concerns, researchers analyzed a federal database of suspected adverse reactions to foods and dietary supplements, comparing reports involving caffeine‑ or stimulant‑containing products with those involving products lacking these ingredients.

The comparison cohort comprised commonly consumed items such as soft drinks, smoothies, vitamins, protein bars, and meal‑replacement shakes. Researchers reviewed reports from individuals aged 13 and older submitted between 2017 and 2025.

• Cardiac arrest: Reports featuring caffeine or stimulant products were roughly 11 times more likely to reference cardiac arrest than reports for products without these ingredients.
• Heart attacks: Heart attacks were reported about 4.5 times more frequently in association with energy drinks and stimulant supplements.
• Abnormal heart rhythms: Reports involving stimulant products were approximately four times more likely to mention ventricular arrhythmias or heart palpitations.
• Other cardiovascular symptoms: Reporting was nearly three times more frequent for rapid heart rate, about 2.7 times more frequent for chest pain, and roughly two times more frequent for fainting.
• Young adults: About 45% of cardiovascular event reports involving caffeine or stimulant products concerned adults aged 18 to 34.
• Men and women: Similar patterns were observed in reports submitted for both men and women.

These differences reflect how often certain medical conditions were reported in the FDA data; they do not indicate that individuals who consume energy drinks experience an 11‑fold increased actual risk of cardiac arrest or a 4.5‑fold increased risk of heart attack.

“Our findings support a need for more systematic safety monitoring of caffeine‑ and stimulant‑containing products, and healthcare professionals should inquire about recent or regular use of these products in younger patients presenting with palpitations, chest pain, or fainting spells,” Samayamanthula said.

Why Young Adults May Be Particularly Vulnerable

A notable aspect of the findings was the high proportion of cardiovascular reports involving younger adults. Researchers have not yet identified why stimulant product use appears so frequently among this age group in relation to reported heart issues.

Potential explanations include higher usage frequency among younger consumers, which increases the likelihood that these products appear in medical emergency reports.

The manner of consumption may also shape the observed pattern. Factors such as use before intense exercise, mixing with alcohol or other drugs, or the presence of previously undiagnosed cardiac conditions could heighten susceptibility to cardiovascular complications.

These hypotheses remain unconfirmed, and further research is required to identify which factors may explain the unusually high reporting frequency among younger adults.

Do Energy Drinks Actually Cause Heart Attacks?

Although the results raise important questions about products with concentrated caffeine and other stimulants, experts caution against interpreting them as proof of a direct causal relationship.

“This study raises concerns that products with very high caffeine amounts may be harmful to the cardiovascular system,” said Gregory M. Marcus, M.D., M.A.S., FAHA, chair of the 2026 American Heart Association scientific statement on caffeine and cardiovascular disease. “While biological mechanisms could plausibly link these products to such events, the study does not prove causality, as other factors may have influenced the observed results. Additional research is needed to determine whether these stimulant products are truly responsible for the reported heart‑related events.”

Marcus did not take part in the research. He is a professor of medicine at the University of California, San Francisco School of Medicine and serves as associate chief of the Cardiology for Research program at UCSF Health.

Because the analysis relied on voluntarily submitted FDA reports, it cannot establish whether the products themselves caused the cardiovascular events; other health conditions, behaviors, or circumstances may also have contributed.

How Researchers Analyzed the FDA Safety Reports

The research team examined 28,345 possible adverse‑event reports submitted to an FDA safety database from 2017 through 2025.

Of these, 854 reports involved energy drinks or dietary supplements containing caffeine or other stimulants, while the remaining 27,491 reports concerned products without caffeine or stimulant ingredients and served as the comparison group.

Researchers classified products by their ingredients. The stimulant category comprised caffeine, methylxanthines (theobromine, guarana, yerba mate, green‑tea/coffee extracts) and sympathomimetics (synephrine, yohimbine, ephedra, DMAA, higenamine).

The researchers also highlighted important data limitations. Because reports were voluntarily submitted by members of the public, consumers, healthcare professionals, and manufacturers, the database does not provide a complete record of all individuals who experienced a possible adverse reaction.

Equally important, the researchers could not determine how many people consumed these products without developing cardiovascular problems, nor could they establish how many experienced heart problems but never submitted a report.

Without these figures, the analysis cannot calculate the actual likelihood of heart attack, cardiac arrest, or other cardiovascular events among consumers of energy drinks and stimulant supplements.

Nevertheless, the findings reveal a potentially important safety signal. Researchers emphasize the need for more systematic monitoring and additional studies to determine whether these products directly contribute to serious heart problems, especially among younger adults who consume them frequently.

Source link